FDA Determines Regulatory Review Period for ANGELMED GUARDIAN SYSTEM Patent Extension

Summary

The US Food and Drug Administration has published a notice determining the regulatory review period for ANGELMED GUARDIAN SYSTEM, a medical device, in response to a patent extension application submitted to the US Patent and Trademark Office.